Dermatitis, also known as eczema, is a group of diseases that results in inflammation of the skin. These diseases are characterized by itchiness, red skin and a rash.
This report contains market size and forecasts of Dermatitis Drugs in global, including the following market information:
Global Dermatitis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dermatitis Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Dermatitis Drugs companies in 2021 (%)
The global Dermatitis Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Calcineurin Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dermatitis Drugs include Regeneron, Bausch Health, Astellas Pharma, Pfizer, Mylan, Bayer, Allergan and LEO Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dermatitis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dermatitis Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dermatitis Drugs Market Segment Percentages, by Type, 2021 (%)
Calcineurin Inhibitors
Corticosteroids
Biologics
Others
Global Dermatitis Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dermatitis Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Dermatitis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dermatitis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dermatitis Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dermatitis Drugs revenues share in global market, 2021 (%)
Key companies Dermatitis Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Dermatitis Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Regeneron
Bausch Health
Astellas Pharma
Pfizer
Mylan
Bayer
Allergan
LEO Pharma